Ms. Feldmann has served as one of our directors since June 2017. In March 2022, Ms. Feldmann joined the board of Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office real estate investing trust focused on collaborative life science, agtech and technology campuses in AAA innovation cluster locations. She serves on the Alexandria board’s Science and Technology Committee. Ms. Feldmann served on the board of Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases, where she also chaired the Frequency Audit Committee from September 2020 until November 2023 when Frequency was combined with Korro Bio(Nasdaq: KRRO) in a reverse merger.
Since 2005, Ms. Feldmann has served on the board of directors of STERIS PLC (NYSE: STE), a provider of infection prevention, decontamination, and health science technologies, products and services. She chairs the STERIS Nominating & Governance Committee and previously chaired and is a current member of the Audit Committee. She also previously served as a member of the STERIS Compliance and Technology Committee.
Ms. Feldmann also served from 2003 to 2018 on the board of directors of Hanger Inc. (NYSE: HNGR), a provider of orthotic and prosthetic services and products, and the largest orthotic and prosthetic managed care network in the U.S. Ms. Feldmann served on the Audit Committee, including as Chair of the Audit Committee, the Compensation Committee and the Quality and Technology Committee of Hanger. From 2013 to 2023 Ms. Feldmann served on the board of trustees and was a member and previously chaired the Finance Committee of Falmouth Academy, an academically rigorous, co-ed college preparatory day school for grades 7 to 12.
Ms. Feldmann previously served as a director and chair of the Audit Committee and as a member of the Nominating and Governance, Compensation, and Quality and Technology Committees of Heartware International, Inc., a Nasdaq-listed medical device company, from 2012 until its acquisition by Medtronic in August 2016. Previously, Ms. Feldmann had a 29-year career in public accounting; she was Partner at KPMG LLP, holding various leadership roles in the firm’s Medical Technology and Health Care & Life Sciences industry groups and was National Partner-in-Charge of the Life Sciences practice for Coopers & Lybrand (now PricewaterhouseCoopers LLP), among other leadership positions she held during her career there.
Ms. Feldmann was a founding board member of Mass Medic, a Massachusetts trade association for medical technology companies, where she also served as treasurer and as a member of the board's Executive Committee during her tenure from 1997 to 2001.
What is Cynthia L. Feldmann's net worth?
The estimated net worth of Cynthia L. Feldmann is at least $848,751.38 as of November 8th, 2024. Ms. Feldmann owns 4,049 shares of UFP Technologies stock worth more than $848,751 as of March 14th. This net worth evaluation does not reflect any other investments that Ms. Feldmann may own. Learn More about Cynthia L. Feldmann's net worth.
How do I contact Cynthia L. Feldmann?
The corporate mailing address for Ms. Feldmann and other UFP Technologies executives is 100 Hale Street, Newburyport MA, 01950. UFP Technologies can also be reached via phone at (978) 352-2200 and via email at investorinfo@ufpt.com. Learn More on Cynthia L. Feldmann's contact information.
Has Cynthia L. Feldmann been buying or selling shares of UFP Technologies?
Cynthia L. Feldmann has not been actively trading shares of UFP Technologies during the past quarter. Most recently, Cynthia L. Feldmann sold 647 shares of the business's stock in a transaction on Friday, November 8th. The shares were sold at an average price of $352.30, for a transaction totalling $227,938.10. Following the completion of the sale, the director now directly owns 4,049 shares of the company's stock, valued at $1,426,462.70. Learn More on Cynthia L. Feldmann's trading history.
Who are UFP Technologies' active insiders?
UFP Technologies' insider roster includes R. Bailly (Chairman and Chief Executive Officer), Steve Cardin (Vice President, Chief Operating Officer, MedTech), Daniel Croteau (Director), Cynthia Feldmann (Director), Jason Holt (Chief Commercial Officer), Ronald Lataille (Sr. Vice President, Treasurer and Chief Financial Officer), Christopher Litterio, Esq (General Counsel and Sr. Vice President of Human Resources), Thomas Oberdorf (Director), and Mitchell Rock (President). Learn More on UFP Technologies' active insiders.
Are insiders buying or selling shares of UFP Technologies?
In the last twelve months, insiders at the industrial products company sold shares 13 times. They sold a total of 88,306 shares worth more than $27,678,095.74. The most recent insider tranaction occured on February, 27th when Director Daniel C Croteau sold 6,846 shares worth more than $1,563,694.86. Insiders at UFP Technologies own 6.2% of the company.
Learn More about insider trades at UFP Technologies. Information on this page was last updated on 2/27/2025.
